Abiopharma

📋 Howard B Rosen (Director) plans to sell 14K shares of KALA BIO, INC. (at $0.29 each, total $4K) Filed: Mar 12, 2026 | ID: 002562

INVESTOR NOTICE: monday.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Czerney Kevin 🟢 acquired 2.9K shares (1 derivative) of DENTSPLY SIRONA Inc. (XRAY) Transaction Date: Mar 11, 2026 | Filing ID: 000112

Fatal incident at Rio Tinto Kennecott

Maersk-Moller Kimberly 🟡 adjusted position in 21.6K shares of MIMEDX GROUP, INC. (MDXG) at $4.50 Transaction Date: Mar 10, 2026 | Filing ID: 000004

Hulse William Frank IV 🟡 adjusted position in 74.9K shares of MIMEDX GROUP, INC. (MDXG) at $4.50 Transaction Date: Mar 10, 2026 | Filing ID: 000007

Mize Gary W. 🔴 sold 107.1K shares of Gevo, Inc. (GEVO) at $2.33 Transaction Date: Mar 12, 2026 | Filing ID: 000002

Shafer Andrew 🟡 adjusted position in 5.5K shares (1 derivative) of Gevo, Inc. (GEVO) at $2.21 Transaction Date: Mar 10, 2026 | Filing ID: 000004

KASINGER JAMES R. 🟡 adjusted position in 2.8K shares (1 derivative) of CRISPR Therapeutics AG (CRSP) at $52.80 Transaction Date: Mar 10, 2026 | Filing ID: 104481

Kulkarni Samarth 🟡 adjusted position in 9.8K shares (1 derivative) of CRISPR Therapeutics AG (CRSP) at $52.80 Transaction Date: Mar 10, 2026 | Filing ID: 104480

DOUG RICE 🟡 adjusted position in 146.6K shares of MIMEDX GROUP, INC. (MDXG) at $4.50 ($1.5M) Transaction Date: Mar 10, 2026 | Filing ID: 000006

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fitzgerald Lindsay Clinton 🔴 sold 20.0K shares of Gevo, Inc. (GEVO) at $2.51 Transaction Date: Mar 12, 2026 | Filing ID: 000002

Westport to Issue Q4 2025 and Full Year 2025 Financial Results on March 26, 2026